Halozyme Therapeutics (HALO) total debt

Total debt · fiscal 2025
$2.14B

Halozyme Therapeutics (HALO) carried total debt of $2.14B at the end of fiscal 2025 (December 31, 2025). That is 42.3% higher than the $1.51B of fiscal 2024. Figures as of 18 Nov 2026, 07:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$2.14B
Change on fiscal 2024
+42.3%
Growth, 5 years
+40.1% a year
Growth, 10 years
+45.7% a year
Highest on record
$2.14Bfiscal 2025
Lowest on record
$0.00fiscal 2011
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Halozyme Therapeutics total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 40.1% a year; over ten years the rate was 45.7% a year. Across the 15 fiscal years on record (2011–2025), the highest was $2.14B in fiscal 2025 and the lowest $0.00 in fiscal 2011.

Total debt was 43.9× shareholders' equity at the end of fiscal 2025.

History · 15 fiscal years

Total debt by fiscal year

Halozyme Therapeutics total debt, year by year

Halozyme Therapeutics (HALO) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$2.14B 42.3% up43.9×
2024$1.51B 0.4% up4.1×
2023$1.50B 0.5% down17.9×
2022$1.51B 71.8% up8.9×
2021$876.67M 120.7% up4.5×
2020$397.23M 1.3% down2.6×
2019$402.59M 218.6% up4.4×
2018$126.38M 37.5% down0.5×
2017$202.35M 6.6% down1.0×
2016$216.62M 334.7% up—
2015$49.83M 0.1% down1.2×
2014$49.86M 0.2% up1.2×
2013$49.77M 67.8% up—
2012$29.66M—0.6×
2011$0.00—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Halozyme Therapeutics and comparable companies
CompanyTotal debtFiscal year
Fresenius Medical Care FMS€10.80B2025
Kymera Therapeutics KYMR$82.25M2025
DaVita DVA$12.87B2025
Halozyme Therapeutics HALO$2.14B2025
Universal Health Services UHS$5.17B2025
Repligen RGEN$689.95M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HALO

Halozyme Therapeutics, figure by figure

Halozyme Therapeutics (HALO) overview: price, valuation and scorecardAll health care companies by market value

Halozyme Therapeutics total debt: questions and answers

How much debt does Halozyme Therapeutics have?

Halozyme Therapeutics (HALO) carried total debt of $2.14B at the end of fiscal 2025 (December 31, 2025). That is 42.3% higher than the $1.51B of fiscal 2024.

What is the growth rate of Halozyme Therapeutics's total debt?

Over the five fiscal years to 2025 total debt grew at a compound 40.1% a year; over ten years the rate was 45.7% a year.

What are the highest and lowest total debt figures on record for Halozyme Therapeutics?

Across the 15 fiscal years on record (2011–2025), the highest was $2.14B in fiscal 2025 and the lowest $0.00 in fiscal 2011.

How does Halozyme Therapeutics's debt compare with its equity?

Total debt was 43.9× shareholders' equity at the end of fiscal 2025.

How is Halozyme Therapeutics's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Halozyme Therapeutics (HALO) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/HALO/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.